Related references
Note: Only part of the references are listed.A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
Yingli Zhang et al.
SCIENTIFIC REPORTS (2021)
Structure and noncanonical Cdk8 activation mechanism within an Argonaute-containing Mediator kinase module
Yi-Chuan Li et al.
SCIENCE ADVANCES (2021)
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases
Xue Chao et al.
BREAST CANCER (2021)
Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases
Srishti Srivastava et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Binding patterns and structure-activity relationship of CDK8 inhibitors
Duo Ma et al.
BIOORGANIC CHEMISTRY (2020)
The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics
Shengjie Zhang et al.
CANCER (2020)
A precisely positioned MED12 activation helix stimulates CDK8 kinase activity
Felix Klatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study
Lili Wang et al.
HUMAN PATHOLOGY (2020)
Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors
Emily M. Schleicher et al.
PLOS GENETICS (2020)
A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis
Bing-ling Peng et al.
THERANOSTICS (2020)
MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women
Mina Darooei et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR
Xiao-Lin Luo et al.
CANCER RESEARCH (2018)
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19
Min Ju Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Notch Signaling in the Tumor Microenvironment
Olivier Meurette et al.
CANCER CELL (2018)
Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women
Ghada M. A. Ajabnoor et al.
FRONTIERS IN GENETICS (2018)
A Computational Protein Phenotype Prediction Approach to Analyze the Deleterious Mutations of Human MED12 Gene
Babajan Banaganapalli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Romain Guieze et al.
BLOOD (2015)
Frequent MED12 mutations in phyllodes tumours of the breast
M. Yoshida et al.
BRITISH JOURNAL OF CANCER (2015)
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer
Eugenia V. Broude et al.
CURRENT CANCER DRUG TARGETS (2015)
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives
Sabrina Croce et al.
EUROPEAN JOURNAL OF CANCER (2015)
MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases
Cedric Chuan Young Ng et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
The Mediator complex: a central integrator of transcription
Benjamin L. Allen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis
Dazhi Xu et al.
NATURE COMMUNICATIONS (2015)
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
Kati Kämpjärvi et al.
Oncotarget (2015)
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
Frank P. Vendetti et al.
ONCOTARGET (2015)
MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs
Lu Wang et al.
SCIENCE ADVANCES (2015)
MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
Netta Mäkinen et al.
Oncotarget (2015)
Molecular Analyses of 6 Different Types of Uterine Smooth Muscle Tumors: Emphasis in Atypical Leiomyoma
Qing Zhang et al.
CANCER (2014)
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Panagiotis Ntziachristos et al.
CANCER CELL (2014)
Redefining the modular organization of the core Mediator complex
Xuejuan Wang et al.
CELL RESEARCH (2014)
MED12 overexpression is a frequent event in castration-resistant prostate cancer
Zaki Shaikhibrahim et al.
ENDOCRINE-RELATED CANCER (2014)
MED12 mutation frequency in unselected sporadic uterine leiomyomas
Hanna-Riikka Heinonen et al.
FERTILITY AND STERILITY (2014)
MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors
Katherine E. Schwetye et al.
HUMAN PATHOLOGY (2014)
Cyclin C is a haploinsufficient tumour suppressor
Na Li et al.
NATURE CELL BIOLOGY (2014)
Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma
Weng Khong Lim et al.
NATURE GENETICS (2014)
Uterine Leiomyoma-Linked MED12 Mutations Disrupt Mediator-Associated CDK Activity
Mikko Turunen et al.
CELL REPORTS (2014)
Mutations in MED12 Cause X-Linked Ohdo Syndrome
Anneke T. Vulto-van Silfhout et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
MED12 exon 2 mutations in histopathological uterine leiomyoma variants
Netta Makinen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours
Akiko Matsubara et al.
HISTOPATHOLOGY (2013)
Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity
Marieke A. de Graaff et al.
HUMAN PATHOLOGY (2013)
MED12 mutations in leiomyosarcoma and extrauterine leiomyoma
Gloria Ravegnini et al.
MODERN PATHOLOGY (2013)
Genetics and biomarkers in personalisation of lung cancer treatment
Rafael Rosell et al.
LANCET (2013)
Characterization of Uterine Leiomyomas by Whole-Genome Sequencing
Miika Mehine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
K. Kampjarvi et al.
BRITISH JOURNAL OF CANCER (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors
Eun Mi Je et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas
Megan M. McGuire et al.
PLOS ONE (2012)
MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
Gaelle Perot et al.
PLOS ONE (2012)
MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling
Haiying Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Philip M. Reaper et al.
NATURE CHEMICAL BIOLOGY (2011)
MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Netta Makinen et al.
SCIENCE (2011)
Molecular Architecture of the Human Mediator-RNA Polymerase II-TFIIF Assembly
Carrie Bernecky et al.
PLOS BIOLOGY (2011)
The hedgehog/Gli signaling paradigm in prostate cancer
Mengqian Chen et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
Cistromics of hormone-dependent cancer
Mathieu Lupien et al.
ENDOCRINE-RELATED CANCER (2009)
The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function
Matthew T. Knuesel et al.
GENES & DEVELOPMENT (2009)
The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator
Matthew T. Knuesel et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The original Lujan syndrome family has a novel missense mutation (p. N1007S) in the MED12 gene
Charles E. Schwartz et al.
JOURNAL OF MEDICAL GENETICS (2007)
A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome
Hiba Risheg et al.
NATURE GENETICS (2007)
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
H. Christian Reinhardt et al.
CANCER CELL (2007)
Mediator modulates Gli3-dependent sonic hedgehog signaling
Haiying Zhou et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Mediator and the mechanism of transcriptional activation
RD Kornberg
TRENDS IN BIOCHEMICAL SCIENCES (2005)
PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator
R Pavri et al.
MOLECULAR CELL (2005)
Ras induces mediator complex exchange on C/EBPβ
XM Mo et al.
MOLECULAR CELL (2004)
Share Paper
